Found 15 matching trials
Multi-CAR-T Cells Targeting B Cell Lymphomas
PHASE1This study aims to evaluate safety and efficacy of a combination of 4th gen...
Location
Shenzhen Geno-Immune Medical Institute
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
PHASE1This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Location
Peking University Shenzhen Hospital
Combination Immunotherapy Targeting Sarcomas
PHASE1The aim of this clinical trial is to assess the feasibility, safety and eff...
Location
Shenzhen Geno-Immune Medical Institute
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
PHASE1The purpose of this clinical trial is to assess the feasibility, safety and...
Location
Shenzhen Geno-Immune Medical Institute
Multi-4SCAR-T Therapy Targeting Breast Cancer
PHASE1The purpose of this study is to assess the feasibility, safety and efficacy...
Location
Shenzhen Geno-immuno Medical Institute
Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma
PHASE1Patients with refractory and/or recurrent neuroblastoma have poor prognosis...
Location
Zhujiang Hospital of Southern Medical University
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
EARLY_PHASE1This is a phase 1, single-center, open-label study that enrolls adult subje...
Location
Lineberger Comprehensive Cancer Center
Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children
NAThis single-arm, multicenter clinical study will treat the patient who have...
Location
Nanjing Children's Hospital
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
PHASE1The body has different ways of fighting infections and disease. No single w...
Location
Emory - Winship Cancer Institute
Combination Immunotherapy Targeting Melanoma
PHASE1The purpose of this study is to assess the feasibility, safety and efficacy...
Location
Shenzhen Geno-Immune Medical Institute